Loading...

Cyfuse Biomedical K.K.

4892.T•JPX
HealthcareDrug Manufacturers - Specialty & Generic
$924.00
$8.00(0.87%)

Cyfuse Biomedical K.K. (4892.T) Stock Overview

Explore Cyfuse Biomedical K.K.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
-10.91%
↓ 10.91%
Profit Growth
$-107.15
↓ 48.03%
EPS Growth
$-107.15
↓ 43.61%
Operating Margin
-1659.75%
↓ 28.49%
ROE
-31.17%
↓ 48.03%
Dividend Yield
0.00%
Analyst Recommendations data is not available for 4892.TAnalyst Recommendations details for 4892.T are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Cyfuse Biomedical K.K. engages in the development, manufacture, and sale of regenerative medicine products in Japan. It develops cellular products in the field of regenerative therapy; and undertakes contract for cellular products for research and development. The company also offers Bio 3D Printer for use in the regeneration of various tissues and organs, such as cartilage and bones, blood vessels, and nerves; regenova, a bio 3D printer for 3D stacking of cells; and S-PIKE that develops 3D-structures from cells. Cyfuse Biomedical K.K. was incorporated in 2010 and is based in Tokyo, Japan.

CEO

Ms. Shizuka Akieda

Employees

21

Headquarters

Sumitomo Fudosan Mita Twin Building, Tokyo

Founded

2022

Frequently Asked Questions

Meyka LogoMeyka

Meyka is the best Alternative Data platform powered by AI providing research insights for investors

Connect With Us

Legal

Resources

Market

Legal Disclaimer

The information provided by Meyka AI PTY LTD is for informational and research purposes only and does not constitute financial, investment, or trading advice. Meyka is a research platform, not a financial advisory service. Investing in financial markets involves risks, and past performance does not guarantee future results. Users should conduct their own due diligence, consult with professional financial advisors, and assess their risk tolerance before making investment decisions. Meyka and its operators are not liable for any financial losses incurred from the use of information on this platform. The data provided is derived from publicly available sources and is believed to be reliable but may not always be accurate or up to date. Users should independently verify information and not rely solely on Meyka for financial decisions. By using Meyka, you acknowledge that it does not provide financial advice or recommendations and agree to seek guidance from a qualified financial professional before making any investment decisions.

© 2025 Meyka AI PTY LTD. All rights reserved.